Infectious Mediastinitis Among the Strasbourg Universitary Hospital, a Retrospective Cohort
Trial Snapshot
- Phase
- Not Applicable
- Sponsor
- Enrollment
- 100
- Locations
- 1
- Primary Endpoint
- Analysis of the cases of mediastinitis and the therapeutic strategy used in recent years at University Hospitals of Strasbourg
Study Overview
Brief Summary
Mediastinitis are rare but serious infections, with mortality rates varying from 6 to 30% according to the literature. They are essentially linked to surgical management (cardio-thoracic in particular), but some forms can be spontaneous, after extension of an ENT infectious focus, for example.
Despite their seriousness, there is no strong recommendations to define their management, especially concerning antibiotic therapy and its duration.
The aim of this research is to make a descriptive analysis of the cases of mediastinitis at HUS in recent years, and to study the therapeutic strategy used
Study Design
- Study Type
- Observational
- Observational Model
- Case Only
- Time Perspective
- Retrospective
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Major subject (≥18 years old)
- •Subject diagnosed with mediastinitis between 01/01/2010 and 31/12/2020
- •Subject not having expressed his opposition, after information, to the reuse of his data for the purposes of this research.
Exclusion Criteria
- •Subject having expressed opposition to participate in the study
- •Subject under guardianship, curatorship or safeguard of justice
Outcomes
Primary Outcomes
Analysis of the cases of mediastinitis and the therapeutic strategy used in recent years at University Hospitals of Strasbourg
Time Frame: Files analysed retrospectively from January 01, 2010 to December 31, 2020 will be examined]
Secondary Outcomes
No secondary outcomes reported